A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor

NCT06758557 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced NSCLC
Advanced Endometrial Cancer

Interventions

DRUG: HB0025
DRUG: Pemetrexed
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Huabo Biopharm Co., Ltd.

Collaborators

[object Object]